One Drop launches cardiovascular prevention tool

NEW YORK – One Drop has released a digital, AI-enabled cardiovascular disease prevention module, the first in its expansion into a wider range of therapeutic areas beyond diabetes management. 

The module, developed in partnership with Bayer Pharmaceuticals, provides members with a personalized digital health program that combines clinical best practices with the latest in technology and predictive analytics to reduce cardiovascular disease risk. 

"The new CVD prevention module comes from combining our respective expertise to jointly bridge the gap between health care and technology," said Jeanne Kehren, CIO and head of digital and commercial innovation, Bayer Pharmaceuticals. "This launch is an important milestone in our joint endeavor with One Drop to make integrated care a transformative solution for the patients and a key player in the health care industry." 

The program includes a user-friendly app that provides a holistic set of digital tools and coaching –personalizing care, gathering data and providing actionable insights. 

The program seeks to reduce the broader burden of disease for those at risk, while lowering costs for employers and health plans. 

"By removing barriers to access to care and critical health information, One Drop instills confidence in our members, equipping them with the tools needed to make intelligent decisions, improve outcomes and reach their full potential," said Rachel Yap Martens, executive vice president of commercial solutions and corporate strategy at One Drop. "The life-altering potential of our cardiovascular disease prevention module would not have been possible without the support and deep expertise from our strategic partner, Bayer. This module is one of many outputs to come, thanks to our productive partnership that will help countless people improve their lives."